Hybio Pharmaceutical Co., Ltd. (SHE:300199)
China flag China · Delayed Price · Currency is CNY
16.25
-0.03 (-0.18%)
Jun 27, 2025, 3:04 PM CST

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2016 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
Preparation
207.64M
Log In
Log In
Log In
Log In
Upgrade
Preparation Growth
-63.91%
Log In
Log In
Log In
Log In
Upgrade
Active Pharmaceutical Ingredient
121.38M
Log In
Log In
Log In
Log In
Upgrade
Active Pharmaceutical Ingredient Growth
35.36%
Log In
Log In
Log In
Log In
Upgrade
Solid
42.39M
Log In
Log In
Log In
Log In
Upgrade
Solid Growth
90.17%
Log In
Log In
Log In
Log In
Upgrade
Consumer Goods and Others
7.10M
Log In
Log In
Log In
Log In
Upgrade
Consumer Goods and Others Growth
766.80%
Log In
Log In
Log In
Log In
Upgrade
Client Peptide
4.37M
Log In
Log In
Log In
Log In
Upgrade
Client Peptide Growth
45.98%
Log In
Log In
Log In
Log In
Upgrade
Equipment
268.75K
Log In
Log In
Log In
Log In
Upgrade
Equipment Growth
-78.70%
Log In
Log In
Log In
Log In
Upgrade
Other
48.25M
Log In
Log In
Log In
Log In
Upgrade
Other Growth
300.95%
Log In
Log In
Log In
Log In
Upgrade
Pharmaceutical Combination Packaging Products
-
Log In
Log In
Log In
Log In
Upgrade
Pharmaceutical Combination Packaging Products Growth
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2016 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
China
319.17M
Log In
Log In
Log In
Log In
Upgrade
China Growth
-48.94%
Log In
Log In
Log In
Log In
Upgrade
Foreign
112.21M
Log In
Log In
Log In
Log In
Upgrade
Foreign Growth
41.58%
Log In
Log In
Log In
Log In
Upgrade